P. Mamers

发表

COMMENT In hibin-Activin Receptor Subunit Gene Expression in Ovarian Tumors

H. Burger, S. Chu, P. Fuller, 2005 .

Inhibin-activin receptor subunit gene expression in ovarian tumors.

H. Burger, S. Chu, P. Fuller, 2002, The Journal of clinical endocrinology and metabolism.

Absence of the previously reported G protein oncogene (gip2) in ovarian granulosa cell tumors.

H. Burger, P. Fuller, P. Mamers, 1996, The Journal of clinical endocrinology and metabolism.

Insulin-like growth factor, insulin-like growth factor–binding protein-4, and pregnancy-associated plasma protein-A gene expression in human granulosa cell tumors

S. Chu, P. Fuller, P. Mamers, 2006, International Journal of Gynecologic Cancer.

Ovarian status in healthy postmenopausal women

M. Oehler, R. Bell, D. Robertson, 2008, Menopause.

Ovarian status in healthy postmenopausal women: follow-up 12 months after transvaginal ultrasound

M. Oehler, R. Bell, D. Robertson, 2009, Menopause.

Inhibins/activins as diagnostic markers for ovarian cancer

H. Burger, N. Groome, D. Robertson, 2002, Molecular and Cellular Endocrinology.

Early follicular phase serum FSH as a function of age: the roles of inhibin B, inhibin A and estradiol

H. Burger, E. Dudley, N. Groome, 2000, Climacteric : the journal of the International Menopause Society.

Inhibin and activin are demonstrable by immunohistochemistry in ovarian tumor tissue.

H. Burger, P. Mamers, T. Jobling, 1995, Gynecologic oncology.

A prospective study of inhibin in granulosa cell tumors of the ovary.

H. Burger, M. Quinn, P. Mamers, 1994, Gynecologic oncology.

The inhibins and ovarian cancer

H. Burger, S. Chu, P. Fuller, 2001, Molecular and Cellular Endocrinology.

Inhibin and ovarian cancer.

H. Burger, N. Groome, P. Fuller, 1998, Journal of reproductive immunology.

Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors.

H. Burger, M. Quinn, J. Campbell, 1994, The New England journal of medicine.

Clinical and pathophysiological aspects of inhibin.

H. Burger, P. Mamers, D. Healy, 1993, Human reproduction.

No evidence of a role for mutations or polymorphisms of the follicle-stimulating hormone receptor in ovarian granulosa cell tumors.

H. Burger, P. Fuller, P. Mamers, 1998, The Journal of clinical endocrinology and metabolism.

FSH-regulated gene expression profiles in ovarian tumours and normal ovaries.

H. Burger, S. Chu, P. Fuller, 2002, Molecular human reproduction.

Molecular characterization of sarcomatous change in a granulosa cell tumor

G. Laslett, G. Laslett, P. Fuller, 2006, International Journal of Gynecologic Cancer.

Elevated Serum Inhibin Concentrations in Postmenopausal Women with Ovarian Tumors

H. Burger, M. Quinn, J. Campbell, 1993 .

Concentrations of immunoactive inhibin in serum during human pregnancy: evidence for an ovarian contribution.

D. D. de Kretser, P. Mamers, D. Healy, 1991, Reproduction, fertility, and development.

Characterization of inhibin forms and their measurement by an inhibin alpha-subunit ELISA in serum from postmenopausal women with ovarian cancer.

H. Burger, N. Groome, D. Robertson, 2002, The Journal of clinical endocrinology and metabolism.

Inhibin forms in serum from postmenopausal women with ovarian cancers

H. Burger, N. Groome, D. Robertson, 1999, Clinical endocrinology.

Characterization of inhibin immunoreactivity in post‐menopausal women with ovarian tumours

H. Burger, N. Groome, N. Groome, 1996, Clinical endocrinology.

Serum inhibin during lactation: relation to the gonadotrophins and gonadal steroids

H. Burger, P. Mamers, M. Bangah, 1994, Clinical endocrinology.

Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses

Kylie L. Gorringe, S. Fox, P. Fasching, 2020, Modern Pathology.

Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma

S. Fox, K. Byth, S. Lade, 2018, Nature Communications.

Inhibin subunit gene expression in ovarian cancer.

H. Burger, S. Chu, P. Fuller, 1999, Gynecologic oncology.

A Casemix Cost Comparison of 2 Treatments For Ectopic Pregnancy

P. Mamers, P. Lowe, D. Healy, 1998, The Australian & New Zealand journal of obstetrics & gynaecology.

Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer

K. Byth, S. Fox, S. Lade, 2014, Scientific Reports.

Laparoscopic and abdominal hysterectomy: a cost comparison

P. Mamers, D. Healy, A. Magnus, 1997 .

Depot Goserelin and Danazol Pre‐Treatment Before Rollerball Endometrial Ablation for Menorrhagia

I S Fraser, P. Mamers, D L Healy, 1996, Obstetrics and gynecology.

Increased microvessel density in mucinous compared with malignant serous and benign tumours of the ovary.

P. Rogers, P. Mamers, M. Orre, 1998, British Journal of Cancer.

H. Burger, S. Chu, P. Fuller, 2022 .

Randomized controlled trial of postoperative pain and activity following microlaparoscopy and standard laparoscopy

C. Goodchild, P. Mamers, D. Healy, 2000 .

Combined inhibin and CA125 assays in the detection of ovarian cancer.

H. Burger, M. McGuckin, K. Pettersson, 1999, Clinical chemistry.

The ageing female reproductive axis I.

H. Burger, L. Dennerstein, E. Dudley, 2002, Novartis Foundation symposium.

Evaluation of serum inhibin A as a surveillance marker after conservative management of tubal pregnancy.

E. Wallace, N. Groome, D. D'Antona, 1998, Human reproduction.

Inhibin gene expression in ovarian cancer

H. Burger, P. Mamers, T. Jobling, 1998 .

Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma

S. Fox, S. Lade, N. Traficante, 2018, Nature Communications.

Production of Inhibin-Related Peptides by Ovarian Tumors

H. Burger, D. Robertson, P. Mamers, 1997 .